Copper/MYC/CTR1 interplay: A dangerous relationship in hepatocellular carcinoma

Cristiana Porcu, Laura Antonucci, Barbara Barbaro, Barbara Illi, Sergio Nasi, Maurizio Martini, Anna Licata, Luca Miele, Antonio Grieco, Clara Balsano

Risultato della ricerca: Contributo in rivistaArticolo in rivista

7 Citazioni (Scopus)


Free serum copper correlates with tumor incidence and progression of human cancers, including hepatocellular carcinoma (HCC). Copper extracellular uptake is provided by the transporter CTR1, whose expression is regulated to avoid excessive intracellular copper entry. Inadequate copper serum concentration is involved in the pathogenesis of Non Alcoholic Fatty Liver Disease (NAFLD), which is becoming a major cause of liver damage progression and HCC incidence. Finally, MYC is overexpressed in most of HCCs and is a critical regulator of cellular growth, tumor invasion and metastasis. The purpose of our study was to understand if higher serum copper concentrations might be involved in the progression of NAFLD-cirrhosis toward-HCC. We investigated whether high exogenous copper levels sensitize liver cells to transformation and if it exists an interplay between copper-related proteins and MYC oncogene. NAFLD-cirrhotic patients were characterized by a statistical significant enhancement of serum copper levels, even more evident in HCC patients. We demonstrated that high extracellular copper concentrations increase cell growth, migration, and invasion of liver cancer cells by modulating MYC/CTR1 axis. We highlighted that MYC binds a specific region of the CTR1 promoter, regulating its transcription. Accordingly, CTR1 and MYC proteins expression were progressively up-regulated in liver tissues from NAFLD-cirrhotic to HCC patients. This work provides novel insights on the molecular mechanisms by which copper may favor the progression from cirrhosis to cancer. The Cu/MYC/CTR1 interplay opens a window to refine HCC diagnosis and design new combined therapies.
Lingua originaleEnglish
pagine (da-a)9325-9343
Numero di pagine19
Stato di pubblicazionePubblicato - 2018


  • CTR1
  • Copper
  • Hepatocellular carcinoma
  • MYC
  • Non alcoholic fatty liver disease
  • Oncology


Entra nei temi di ricerca di 'Copper/MYC/CTR1 interplay: A dangerous relationship in hepatocellular carcinoma'. Insieme formano una fingerprint unica.

Cita questo